Literature DB >> 25804944

The dangers of iodine-based contrasts in an elderly patient with thyroid disease.

David Ledingham1, Peter Carey2, Shahid Junejo1.   

Abstract

Iodine-based contrast agents are widely used in angiographic and other radiological procedures. Clinicians are familiar with many of the potential adverse events from contrast agents including allergic reactions and contrast-induced nephropathy. This case describes a lesser known adverse event: 'contrast-induced thyrotoxicosis' and its implications on the presentation and management of a patient with severe coronary artery disease. The management of this case was difficult and required a long inpatient admission with use of prednisolone, propylthiouracil and planned treatment with radioiodine to control the thyrotoxicosis, as well as the use of several rate-limiting agents and antianginal medications to control atrial fibrillation and prevent further episodes of angina. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25804944      PMCID: PMC4386479          DOI: 10.1136/bcr-2014-207657

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

Review 1.  Thyroid hormone and the cardiovascular system.

Authors:  I Klein; K Ojamaa
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

2.  How many cath labs do we need?

Authors:  D Hackett
Journal:  Heart       Date:  2003-08       Impact factor: 5.994

3.  Plasma inorganic iodide as a homeostatic regulator of thyroid function.

Authors:  J WOLFF; I L CHAIKOFF
Journal:  J Biol Chem       Date:  1948-06       Impact factor: 5.157

4.  Jod-Basedow syndrome following oral iodine and radioiodinated-antibody administration.

Authors:  A M El-Shirbiny; S S Stavrou; A Dnistrian; M Sonenberg; S M Larson; C R Divgi
Journal:  J Nucl Med       Date:  1997-11       Impact factor: 10.057

5.  Iodine-induced hyperthyroidism due to nonionic contrast radiography in the elderly.

Authors:  F I Martin; B W Tress; P G Colman; D R Deam
Journal:  Am J Med       Date:  1993-07       Impact factor: 4.965

Review 6.  Thyroid disease and the heart.

Authors:  Irwin Klein; Sara Danzi
Journal:  Circulation       Date:  2007-10-09       Impact factor: 29.690

7.  Effect of iodinated contrast media on thyroid function in adults.

Authors:  Aart J van der Molen; Henrik S Thomsen; Sameh K Morcos
Journal:  Eur Radiol       Date:  2004-02-28       Impact factor: 5.315

8.  Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study.

Authors:  Lars Frost; Peter Vestergaard; Leif Mosekilde
Journal:  Arch Intern Med       Date:  2004 Aug 9-23

Review 9.  Iodide-induced thyrotoxicosis.

Authors:  J E Fradkin; J Wolff
Journal:  Medicine (Baltimore)       Date:  1983-01       Impact factor: 1.889

10.  Iodine-induced hyperthyroidism-an old clinical entity that is still relevant to daily ICU practice: a case report.

Authors:  E Brotfain; L Koyfman; A Frenkel; A Smolikov; A Zlotnik; M Klein
Journal:  Case Rep Endocrinol       Date:  2013-04-09
View more
  4 in total

1.  Coronary physiology and percutaneous intervention managed with gadolinium road mapping and intravascular ultrasound in hyperthyroidism.

Authors:  Peter Tajti; Mohamed Ayoub; Thomas Nuehrenberg; Kambis Mashayekhi
Journal:  Cardiol J       Date:  2021-03-01       Impact factor: 2.737

2.  2021 European Thyroid Association Guidelines for the Management of Iodine-Based Contrast Media-Induced Thyroid Dysfunction.

Authors:  Tomasz Bednarczuk; Thomas H Brix; Wolfgang Schima; Georg Zettinig; George J Kahaly
Journal:  Eur Thyroid J       Date:  2021-06-16

3.  Heart failure as a serious complication of iodinated contrast-induced hyperthyroidism: case-report.

Authors:  Sofie M Diepenbroek; A de Jonghe; C van Rees; E Seebus
Journal:  BMC Endocr Disord       Date:  2021-10-20       Impact factor: 2.763

4.  Case Report: Atrial Fibrillation After Intravenous Administration of Iodinated Contrast Medium in a Patient With Hepatocellular Carcinoma.

Authors:  Sergio Maimone; Roberto Filomia; Carlo Saitta; Giovanni Raimondo; Giovanni Squadrito
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.